GlassScriptPhysician profile
Sterling Scott Mcclain
NPI 1700376076
$478.10
in general payments reported to CMS, 2019-2025
17 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $146 · 2024: $153 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $64.58 | 2023-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Channel Medsystems, INC. | $62.12 | 2025 | |
| Shield Therapeutics INC | $35.22 | 2024 | |
| Organon LLC | $34.79 | 2024 | |
| Abbvie INC. | $31.94 | 2023-2024 | |
| Exeltis, USA INC. | $31.90 | 2023-2025 | Slynd |
| Takeda Pharmaceuticals U.S.A., INC. | $30.62 | 2023 | Trintellix |
| Smith+Nephew, INC. | $26.14 | 2025 | Pico |
| Biogen, INC. | $24.72 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $21.49 | 2023 | Injectafer |
| Astellas Pharma US INC | $19.71 | 2025 | Veozah |
| Coopersurgical, INC. | $19.27 | 2024 | Paragard T 380a |
| Medtronic, INC. | $18.57 | 2024 | Valleylab Ft10 |
| Sumitomo Pharma America, INC. | $15.01 | 2023 | Gemtesa |
| Pfizer INC. | $14.44 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $14.00 | 2024 | Harmonic |
| Optumhealth Care Solutions, LLC | $13.58 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sterling Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.